Study of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid Tumors
Status:
Recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
This phase I/II trial aims to evaluate safety and efficacy of Chidamide, Decitabine and
Immune checkpoint inhibitors in relapsed/refractory Non-Hodgkin Lymphoma and advanced solid
tumors.